Incyte Investor Event At AACR 2016 To Highlight Innovative And Diversified Research And Development Portfolio

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) will highlight the productivity of its drug discovery and development organization and aspects of its development portfolio at an investor event on Sunday, April 17, 2016 at the American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans, Louisiana.
MORE ON THIS TOPIC